Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diacerein for adult simple obesity
ChiCTR2200062908Phase 4Not yet recruiting
- Sponsor
- Jiangsu Provincial Hospital of Traditional Chinese Medicine
- Start
- Jul 2022
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of diacerein in obesity (2 arms), sponsored by Jiangsu Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Body mass index, Weight and 1 more. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
diacerein
03
Conditions
obesity
Beyond the preview
Go deeper on ChiCTR2200062908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062908.